> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Joint Panel Meeting to Discuss Pain Drug
- URL: https://www.fdaweb.com/fda-joint-panel-meeting-to-discuss-pain-drug/
- Published: 2017-03-14T12:00:00.000Z
- Updated: 2026-09-14T22:11:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138198

*Federal Register* Notice: FDA has announced a 4/5 joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee. The committees will discuss an Inspirion Delivery Sciences NDA for oxycodone hydrochloride immediate-release oral tablets, indicated for management of moderate to severe pain where the use of an opioid analgesic is appropriate. The product has been formulated with properties intended to deter abuse, and the applicant has submitted data to support these properties.